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EVIDENCE OF IN VIVO EXISTENCE OF BORRELIA BIOFILM
IN BORRELIAL LYMPHOCYTOMAS
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1 Department of Biology and Environmental Science, University of New Haven, West Haven, CT 06516, USA
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Lyme borreliosis, caused by the spirochete Borrelia burgdorferi sensu lato, has grown into a major public health problem. We re-
cently identified a novel morphological form of B. burgdorferi, called biofilm, a structure that is well known to be highly resistant 
to antibiotics. However, there is no evidence of the existence of Borrelia biofilm in vivo; therefore, the main goal of this study was 
to determine the presence of Borrelia biofilm in infected human skin tissues. Archived skin biopsy tissues from borrelial lympho-
cytomas (BL) were reexamined for the presence of B. burgdorferi sensu lato using Borrelia-specific immunohistochemical staining 
(IHC), fluorescent in situ hybridization, combined fluorescent in situ hybridization (FISH)–IHC, polymerase chain reaction (PCR), 
and fluorescent and atomic force microscopy methods. Our morphological and histological analyses showed that significant 
amounts of Borrelia-positive spirochetes and aggregates exist in the BL tissues. Analyzing structures positive for Borrelia showed 
that aggregates, but not spirochetes, expressed biofilm markers such as protective layers of different mucopolysaccharides, espe-
cially alginate. Atomic force microscopy revealed additional hallmark biofilm features of the Borrelia/alginate-positive aggregates 
such as inside channels and surface protrusions. In summary, this is the first study that demonstrates the presence of Borrelia bio-
film in human infected skin tissues.
Keywords: Lyme disease, biofilm, mucopolysaccharides, alginate, atomic force microscopy
Abbreviations: AEC, 3-amino-9-ethylcarbazole; ATCC, American Type Culture Collection; AFM, atomic force microscopy;
BL, borrelial lymphocytoma; BSA, bovine serum albumin; BSK-H, Barbour–Stoner–Kelly H; DAPI, 4 ,´6-diamidino-2-phenylin-
dole; DIC, differential interference contract microscopy; EDTA, ethylenediaminetetraacetic acid; FAM, 6-fluorescein amidite; 
FFPE, formalin-fixed, paraffin-embedded; FISH, fluorescent in situ hybridization; FITC, fluorescein isothiocyanate; H&E, hema-
toxylin and eosin; IRB, Institutional Review Board; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; RT, room 
temperature; SSC, saline sodium citrate
Introduction
Lyme disease, transmitted by the bite of infected ticks of 
the Ixodes genus, is an infectious disease caused by spiro-
chetes belonging to the genus Borrelia [1]. Lyme disease 
is estimated to affect 300,000 people a year in the United 
States and 65,000 people per year in Europe [2].
Lyme disease patients are treated with various anti-
biotics though the rates of relapse and recurrence of the 
disease are frequent after discontinuing the antibiotic treat-
ment [3–7]. It was proposed earlier that the observed anti-
biotic resistance and reoccurrence of Lyme disease might 
be due to the formation of defensive morphological forms 
of Borrelia burgdorferi [8–10].
In addition to its familiar spirochete form, B. burg-
dorferi can transform from motile spirochetes into round 
body forms in the presence of various unfavorable envi-
ronmental conditions including the presence of antimi-
crobial agents [11–17]. The presence of those alternative 
forms was confi rmed with numerous in vitro and in vivo 
studies; it was also proven that they respond to different 
antibiotic treatments than the spirochetal forms [18–22]. 
However, despite the fact that we might have good un-
derstanding about the effective treatment for those known 
alternative forms, in vivo studies still reported an uncul-
tivable but infective form of B. burgdorferi, which could 
evade even the most aggressive antimicrobial treatments 
[23–26].
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Searching for potential answers for the observed high 
antibiotic resistance in vivo, we identifi ed that this bacte-
rium has an additional morphological form, called biofi lm, 
a form which is very well known for allowing the bacteria 
to survive in adverse environmental conditions [27–31]. 
We provided evidence for the in vitro existence of borrelial 
biofi lm using several known hallmark biofi lm features in-
cluding structural rearrangements in the aggregates pro-
ducing a complex structure with channel and protrusions, 
a common feature in biofi lm forming Pseudomonas ae-
ruginosa, Azotobacter vinelandii, and Leptospira bifl exa 
[32–37]. We also provided evidence that B. burgdorferi 
sensu stricto and sensu lato aggregates have specifi c sur-
face biofi lm markers such as alginate [30, 38], a muco-
polysaccharide which is well characterized in biofi lms of 
other pathogenic bacteria [39].
In addition, we and others have demonstrated that 
B. burgdorferi aggregate formation enhances the antibiot-
ic resistance of the organism to various antibiotics, which 
previously showed some success against the spirochete 
and round body forms of B. burgdorferi [20–22, 40]. Tak-
en together, these in vitro observations of biofi lm forma-
tion suggest that B. burgdorferi could play signifi cant role 
in their survival in diverse environmental conditions, by 
providing refuge to individual cells. However, the question 
remains if these structures can be found in vivo and wheth-
er these biofi lm structures hold signifi cant relevance for 
the survival strategies for Borrelia spp. in infected tissues.
In order to answer this question, we reexamined the 
fi ndings from our earlier studies where we have seen simi-
lar Borrelia aggregates in infected skin tissues. We previ-
ously investigated different infected biopsy sections from 
known cutaneous complication of Lyme disease such as 
erythema chronicum migrans, borrelial lymphocytoma, 
and Borrelia acrodermatitis chronica atrophicans for the 
presence of Borrelia-positive structures [41]. We observed 
individual spirochetes in the sections as well as putative 
aggregates especially in the borrelial lymphocytoma (BL) 
tissues. These structures are strikingly similar to the ones 
we have previously seen and characterized in our in vitro 
culture systems that were proven to be biofi lm [30].
Borrelial lymphocytoma, which develops weeks to 
months after the tick bite, is a rare but typical manifestation 
of Lyme disease found mainly in Europe [41, 42]. Because 
the low sensitivity of the available serology and molecular 
biology techniques, clinical diagnosis for BL still relies on 
clinical presentation and histological examination of the 
infected tissues [41, 42]. For example, histologic examina-
tion of cutaneous borrelial infections, including BL, usu-
ally reveals an infi ltrate of lymphocytes, macrophages, and 
plasma cells in cutaneous lesions with “acral” predilection 
which are very characteristic of BL [41, 42].
Therefore, in this study, we used BL skin biopsies to 
evaluate whether the surface of Borrelia-positive aggre-
gates could contain different mucopolysaccharides, espe-
cially alginate, to provide evidence for the existence of 
Borrelia biofi lm in vivo. First, we used Borrelia-specifi c 
immunohistochemical (IHC), fl uorescent in situ hybrid-
ization (FISH), and polymerase chain reaction (PCR) tech-
niques to fi nd Borrelia spirochetes and aggregates in the 
archived tissue biopsies from BL cases. We then further 
analyzed the surface of Borrelia-positive aggregates for 
potential mucopolysaccharides using different histologi-
cal, IHC, combined IHC–FISH, and atomic force micros-
copy methods to further analyze those Borrelia/alginate-
positive structures.
Materials and methods
Human tissue samples, processing biopsy specimens
From the fi les of our dermatohistopathologic laboratory, 
archived paraffi n materials were retrieved from January 
1975 to December 2005 from six cases of clinically con-
fi rmed borrelial lymphocytoma by certifi ed dermatopa-
thologists. All six cases had positive serology for Borrelia 
IgG, and characteristic features of borrelial lymphocytoma 
with “acral” predilection were found. All six patients were 
female (average age = 33 years) from endemic areas of 
Borreliosis in Austria with a rate of positive serology in the 
population between 30 and 60%. PCR confi rmation for all 
six cases were performed independently in two different 
laboratories located in Austria and the US. The archival 
hematoxylin and eosin (H&E)-stained sections were re-
examined, and the previous diagnosis also confi rmed by 
two of us (B.Z. and A.M.D.). Institutional Review Board 
(IRB) exemption for this study was obtained from Univer-
sity of New Haven.
The paraffi n blocks were sectioned by McClain Labo-
ratories LLC (Smithtown NY) at 4 μm on TRUBOND200 
adhesive slides. The sections then were deparaffi nized by 
washing the sections three times in 100% xylene for 5 min 
each followed by rehydration in a series of graded alco-
hols (100%, 90%, and 70%) and washed in 1× phosphate-
buffered saline (PBS) pH 7.4 for 5 min. For the immuno-
histochemical experiments, the tissues were incubated in 
10 mM sodium citrate buffer for 45 min at 95 °C for anti-
body retrieval for the immunohistochemical experiments. 
For silver penetration method, the modifi ed Dieterle meth-
od was used by the McClain Histopathology Laboratories 
LLC (Smithtown NY) following a previously published 
procedure by Duray P. et al. [43].
Bacterial cultures
Low passage isolates (<p3) of B. burgdorferi B31 (ATCC 
no. 35210), Borrelia garinii (ATCC no. 51991), Borrelia af-
zelii (ATCC no. 51992), and Treponema denticola (ATCC 
no. 33520) were obtained from American Type Culture 
Collection (ATCC). Borrelia hermsii was received from 
Dr. Tom G. Schwan’s laboratory at Rocky Mountain Lab-
oratories, NIH. Cells were maintained in Barbour–Ston-
er–Kelly H (BSK-H, Sigma) media supplemented with 
6% or 12% (for T. denticola and B. hermsii) rabbit serum 
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(Pel-Freeze) without antibiotics in sterile 15 ml glass tubes 
and incubated at 33 °C with 5% CO2. Escherichia coli bio-
fi lm forming strain was obtained from ATCC (ATCC no. 
25922) and cultured overnight at 37 °C with shaking at 
200 rpm in sterile 50 ml centrifuge tubes containing Luria 
broth media (Difco).
Slide preparation for in vitro experiments
Cell concentrations were determined using the Petroff-
Hausser counting chamber method. A total of 1 × 106 cells 
per milliliter were centrifuged at 4000×g for 10 min at 
room temperature (RT) to remove the media. The super-
natant was discarded, pellet was washed two times with 
1 ml of 1× PBS (pH 7.4) and then resuspended in 100 μl 
of 1× PBS (pH 7.4), and the samples were smeared onto 
glass microscope slides (Superfrost+, Thermo Scientifi c). 
The smear was allowed to completely dry in a laminar air-
fl ow chamber, followed by fi xation with ice-cold acetone 
for 15 min. Slides were then washed twice with 1× PBS 
(pH 7.4) at RT and used for the experiments.
Immunohistochemistry methods (IHC)
Two independent immunohistochemistry methods were 
performed as described before [30, 41]. Initially, the ar-
chived BL biopsy samples were immunostained with 
Borrelia-specifi c antibody to confi rm the presence of Bor-
relia spp. in Innsbruck Medical University, utilizing the 
Ventana-KIT (Ventana Medical Systems, Munich, Ger-
many). In this method, a biotinylated secondary antibody 
and a third layer of streptavidin–biotin horseradish per-
oxidase complex were utilized. As a fi nal reaction product, 
3-amino-9-ethylcarbazole (AEC) was used with bright red 
which proved to be superior to the brown diaminobenzi-
dine. Negative control experiments were performed by 
omitting the primary antibody in an otherwise identical 
immunohistochemical procedure.
To further confi rm the presence of Borrelia spp. in 
these tissues, the immunostaining was repeated at the Uni-
versity of New Haven using a previously published immu-
nofl uorescence protocol [30]. The Borrelia–alginate dou-
ble staining IHC was performed in two different ways. On 
the same slides using the primary antibodies sequentially 
or consecutive slides using the two primary antibodies in 
parallel to provide information whether the two primary 
antibodies would have cross-reaction with the correspond-
ing secondary antibodies. On the same slide method, the 
deparaffi nized BL sections were fi rst blocked with 10% 
normal goat serum (Thermo Scientifi c) in 1× PBS pH (7.4) 
for 30 min at RT to block nonspecifi c binding of the sec-
ondary antibody. The slides were then washed two times 
with PBS/0.5% bovine serum albumin (BSA) for 5 min 
each and further incubated at 37 °C for 1 h with fl uores-
cein isothiocyanate (FITC)-labeled Borrelia-specifi c poly-
clonal antibody (#73005 Thermo Scientifi c, diluted 1:50 in 
1× PBS/0.5% BSA). The slides were washed with 1× PBS 
fi ve times for 5 min each at RT and counterstained with Su-
dan black (Sigma) and/or 4´,6-diamidino-2-phenylindole 
(DAPI) for 10 min. The slides were washed again with 1× 
PBS for 5 min, dried and mounted with PermaFluor aque-
ous mounting medium (Thermo Scientifi c). Images were 
acquired by fl uorescent microscopy (Leica DM2500). On 
immunostaining method on sequential slides, the two pri-
mary antibodies were used in parallel experiment. For the 
IHC, two additional negative controls were used: 1) omit-
ting primary antibody (use only 1× PBS + 0.5% BSA) and 
2) normal human foreskin samples purchased commer-
cially.
Spicer & Meyer mucopolysaccharide staining
The staining was performed as described previously with 
minor modifi cations [30]. Briefl y, Borrelia aggregates on 
the deparaffi nized and hydrated BL biopsy sections were 
stained with aldehyde fuchsine solution (Sigma-Aldrich, 
0.5% fuchsine dye, 6% acetaldehyde in 70% ethanol with 
1% concentrated hydrochloric acid) for 20 min. After im-
mersing the slides in 70% ethanol for 1 min and having 
it rinsed with double-distilled water for another minute, 
the aggregates were sequentially stained with 1% Alcian 
blue 8GX (Sigma-Aldrich, dissolved in 3% acetic acid, 
pH 2.5) for 30 min. The slides were rinsed with double dis-
tilled water for 3 min and dehydrated using chilled graded 
ethanol washes (50%, 70%, and 95%, 3 min each). The 
slides were then immersed in chilled xylene for 2 min and 
mounted with Permount media (Fisher Scientifi c). Images 
were analyzed using different microscopy methods (see 
Results section).
Genomic DNA extraction
Genomic DNA was extracted from B. afzelii BO23 labora-
tory strain (ATCC no. 51992) using Qiagen DNeasy Blood 
and Tissue Kit (Qiagen) according to the manufacturer’s 
instructions. All samples were stored at −20 °C until analy-
sis. Genomic DNA from paraffi n-embedded tissues fi xed 
on glass slides was extracted using the Qiagen QIAamp 
DNA Formalin-fi xed, Paraffi n-Embedded (FFPE) Tissue 
Kit (Qiagen). First, the slides were deparaffi nized, and 
then any tissues present on the slides were scraped off us-
ing sterile blades and collected in sterile microcentrifuge 
tubes. One hundred eighty microliters of ATL buffer and 
20 μl of proteinase K were added to the tubes, and the sam-
ples were incubated overnight at 42 °C and then at 90 °C 
for 1 h to deactivate the enzyme. Two hundred microli-
ters of AL buffer and an additional 200 μl of 96% ethanol 
were added to the samples and vortexed thoroughly. The 
samples were then transferred to DNeasy mini columns 
and centrifuged for 1 min at 6000×g. The fl ow-through 
was discarded, and the columns were placed into new 
collection tubes. To wash away any unwanted materials 
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that might be present along with the DNA, 500 μl of AW1 
and AW2 buffers was added to the columns consecutively 
and centrifuged at 6000×g for 1 min. The spin columns 
were placed then in fresh collection tubes and centrifuged 
at 20,000×g for 3 min to completely dry the column. The 
columns were then placed in new microcentrifuge tubes, 
and the samples were eluted twice with 50 μl of ATE buf-
fer. The samples were quantifi ed using BioTek Microplate 
Spectrophotometer (BioTek) and stored at −20 °C until 
analysis.
PCR/DNA sequencing
PCR reactions were performed using primers designed 
to amplify B. burgdorferi sensu lato 16S ribosomal RNA 
small subunit. The 16S rRNA gene was amplifi ed in a sin-
gle reaction using primers F: 5´-CCTGGCTTAGAACTA-
ACG-3´ and R: 5´-CCTACAAAGCTTATTCCTCAT-3´ 
in a 50-μl reaction containing HotStarTaq buffer (Qiagen) 
1.5 mM MgCl2, 25 pmoles of each primer, and 2.5 units of 
HotStarTaq DNA polymerase (Qiagen). The PCR reaction 
consisted of an initial denaturation at 94 °C for 15 min, fol-
lowed by 40 cycles of 94 °C/30 s, 50 °C/30 s, 72 °C/1 min, 
and then a fi nal extension at 72 °C/5 min. The PCR prod-
ucts were analyzed by standard agarose gel electrophore-
sis. PCR products were purifi ed using the QIAquick PCR 
purifi cation kit (Qiagen) according to the manufacturer’s 
instructions. Samples were eluted twice in 30 μl, and the 
eluates from each sample were pooled and sequenced in 
both directions twice (4× coverage) using the same prim-
ers that generated the products. All DNA sequencings were 
performed by Eurofi ns/MGW/Operon (Huntsville, AL).
Fluorescent in situ hybridization (FISH)
A 32-base-long oligonucleotide probe was designed for 
B. burgdorferi sensu lato species-specific 16S ribosom-
al DNA (5´-GGATATAGTTAGAGATAATTATTCCCC-
GTTTG-3´). The probe was designed to hybridize with 
B. burgdorferi, B. garinii, and B. afzelii, but not with T. den-
ticola and E. coli strains (see validation study below). As 
a negative control, a 32-base-long random oligonucleotide 
probe (5´-GCATAGACATGAGATATACTGTACTAG-3´) 
was also designed. Both probes were synthesized and la-
beled with 6-fl uorescein amidite (FAM) at the 5´ end by 
Eurofi ns MWG Operon oligonucleotide services. In situ 
hybridization probes were prepared by mixing 100 ng of 
labeled oligonucleotide with 2.5 μg salmon sperm DNA 
(Life Technologies) plus with 0.1 volume 3M sodium ac-
etate (Fisher Scientifi c) and 2 volumes of ice cold ethanol, 
and the mixture was allowed to precipitate at −80 °C for 
1 h. Probes were then centrifuged at 14,000 rpm for 20 min 
and resuspended in 10 μl hybridization buffer (50% v/v for-
mamide [Sigma], 10% w/v dextran sulfate [Sigma], 1% v/v 
Triton X-100 [Sigma], and 2× saline sodium citrate [SSC] 
pH 7.0). Probes were then warmed to RT for 10 min, dena-
tured at 95 °C for 10 min, and immediately cooled on ice 
for 10 min. Slides containing fi xed cells were denatured in 
denaturing solution (70% v/v formamide, 2× SSC, 0.1 mM 
ethylenediaminetetraacetic acid [EDTA] pH 7.0) at 70 °C 
for 5 min and washed twice with cold 2× SSC followed by 
dehydration through a series of cold alcohol washes (70%, 
90%, 100%). The sections were hybridized with the probe 
in the dark at 48 °C for 24 h. After hybridization, slides 
were washed three times with 2× SSC for 3 min each at RT 
followed by two 20 min washes in 0.1× SSC at 42 °C and a 
fi nal wash in 0.1× SSC at RT. Finally, slides were blocked 
with freshly made blocking solution (3% w/v BSA [Fisher] 
in 4× SSC, 0.1% v/v Triton X-100) for 3 min and washed 
with a wash solution (4× SSC, 0.1 % v/v Triton X-100) for 
3 min at room temperature.
For the paraffi n-embedded tissue sections, the slides 
were fi rst deparaffi nized by heating on a slide warmer for 
40 min at 45 °C and immersed in 100% xylene for 5 min 
three times. The slides were rehydrated in series of graded 
alcohols (100%, 90%, and 70%) and washed in PBS for 
5 min and in distilled water for 15 min to rehydrate the 
tissues. The slides were treated with 4% sodium borohy-
dride (Sigma-Aldrich) for 20 min on ice. The tissues were 
digested with prewarmed proteinase K solution (20 μg/ml 
in 50 mM Tris) for 10 min at 37 °C and refi xed with 4% 
paraformaldehyde for 10 min at room temperature. The 
slides were denatured using preheated denaturing buffer 
(70% v/v formamide, 2× SSC, and 0.1 mM EDTA [Fisher] 
pH 7) at 70 °C followed by prehybridization for 4 h in hy-
bridization buffer (50% v/v formamide [Sigma], 10% w/v 
dextran sulfate [Sigma], 1% v/v Triton X-100 [Sigma], 2× 
SSC, [Sigma] pH 7.0, and 2 ng of salmon sperm DNA) 
in an incubator at 48 °C. The sections were hybridized 
with the probe at 48 °C for 18 h in dark. After hybridiza-
tion, slides were washed three times with 2× SSC for 3 
min each at room temperature followed by fi ve 20 min 
washes in 0.1× SSC at 42 °C and a fi nal wash in 2× SSC 
at room temperature. Finally, slides were blocked with 
freshly made blocking solution (3% w/v BSA [Fisher] in 
4× SSC, 0.1% v/v Triton X-100) for 30 min and washed 
with wash solution (4× SSC, 0.1 % v/v Triton X-100) for 
3 min at room temperature. All steps were repeated with 
several controls such as: 1) 100 ng negative control ran-
dom oligonucleotide, 2) 200 ng of unlabeled competing 
oligonucleotide present during the hybridization, and 
3) following a DNase treatment of the sections before the 
hybridization step to digest all genomic DNA (100 μg/
ml for 60 min at 37 °C). All slides were then analyzed by 
fl uorescent microscopy using a Leica DM2500 biomedi-
cal microscope.
Combined FISH and IHC analyses
For the paraffi n-embedded tissue sections, slides were 
fi rst deparaffi nized, rehydrated, and pretreated, and in situ 
hybridization protocol was followed as described above 
in the FISH section. After the last 0.2× SSC wash, the 
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sections were blocked with a 1:100 dilution of goat se-
rum (Thermo Scientifi c) in 1× PBS pH 7.4 (Sigma) for 
30 min at room temperature in a humidifi ed chamber. The 
sections were then washed twice in 1× PBS (Sigma) for 
5 min. Slides were then treated with a 1:500 dilution of 
primary anti-alginate antibody (provided by Dr. Gerald 
Pier, Harvard Medical School) in 1× PBS and placed in 
a humidifi ed chamber overnight at room temperature and 
then washed twice in 1× PBS for 5 min and in distilled 
water for 5 min. Slides were then treated with a 1:200 dilu-
tion of a secondary anti-rabbit antibody with a fl uorescent 
blue tag (405 nm, Thermo Scientifi c) for 1 h in a humidi-
fi ed chamber at room temperature. The sections were then 
washed twice in 1× PBS for 5 min and in distilled water for 
5 min. Sections were then washed in 0.2× SSC for 5 min 
in the dark at room temperature. Sections were then coun-
terstained with Sudan Black (Sigma) for 20 min. Sections 
were mounted with PermaFluor (Thermo Scientifi c), and 
images were captured using a Leica DM2500 fl uorescent 
microscope. As a negative control, all steps were repeated 
with 200 ng of competing unlabeled oligonucleotide pres-
ent during the hybridization.
Atomic force microscopy
The Borrelia/alginate-positive structures were visualized 
at nanometer-scale resolution through atomic force mi-
croscopy (AFM) analyses. First, the biopsy section was 
hydrated overnight at RT with 1× PBS (pH 7.4) buffer 
and rinsed with double distilled water two times before 
the scan. AFM scans on BL tissues were performed in 
contact mode using the Nanosurf Easyscan 2 AFM (Nano-
surf) with SHOCONG probe (AppNANO™). Images 
were taken by Hamamatsu ORCA Digital Camera. Images 
were processed, and measurements were obtained using 
Gwyddion software.
Statistical analysis
Statistical analysis was performed using Student’s t-test 
(Microsoft Excel, Redmond, WA) on the number of ob-
served spirochetes and aggregates found in the 200 sec-
tions of the six BL specimens. Statistical signifi cance was 
determined based on p value <0.05.
Fig. 1. Representative immunohistochemical (IHC) images of borrelial lymphocytoma (BL) tissue sections stained with Borrelia-
specific antibody following an IHC protocol as described earlier [41]. Positive Borrelia staining is depicted by red color. 200× 
magnification, bar: 100 μm
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Results
Presence of  Borrelia spirochetes and aggregates
in BL tissues sections
The overall goal of this study was to reexamine cutane-
ous cases of BL tissues to examine the potential presence 
of Borrelia biofi lms in vivo. First, six cases of borrelial 
lymphocytoma archived tissues were retrieved from the 
fi les of our Dermatohistopathologic Laboratory in the De-
partment of Dermatology and Venereology, Medical Uni-
versity Innsbruck. Archival H&E-stained sections were 
reexamined, and previous diagnoses were confi rmed by 
two of us (B.Z. and A.M.D.). The presence of Borrelia 
was confi rmed independently by two previously published 
immunohistochemical methods [41] in Medical University 
Innsbruck (Innsbruck, Austria) and in University of New 
Haven (West Haven, CT) combined with silver staining 
method performed in McClain Laboratory (Long Island, 
NY). Figure 1 shows the representative images of the im-
munohistochemistry results of the six BL cases performed 
in Medical University Innsbruck. In all BL cases, the pres-
ence of Borrelia spirochetes and aggregates was clearly 
visible (red staining). Figure 1E and F show the presence 
of Borrelia-positive aggregates which were the subject for 
our further studies.
To further confi rm the presence of Borrelia in the BL 
tissues, modifi ed Dieterle method silver staining tech-
niques were performed independently in McClain histopa-
thology laboratories (Smithtown, NY). Figure 2A shows 
representative images of silver staining results on the BL 
tissues sections demonstrating silver stain positive spiro-
chetal structures (Fig. 2, panels Ai and iv) as well as dif-
ferent sizes of silver-stained positive aggregates (Fig. 2, 
panels Aii and iii).
Aggregates which were positive for silver staining were 
then subjected to additional studies by immunostaining at 
the University of New Haven (West Haven CT, USA) of 
the consecutive sections with a different Borrelia-specifi c 
antibody to confi rm that they are borrelial aggregates. Fig-
ure 2B shows that a silver-stained structure (can be found 
in both panel Aiii and panel Bv), but not the “no antibody” 
control (Fig. 2, panel Bvii), indeed stained positively with 
Borrelia antibody (Fig. 2, panel Bvi, green fl uorescent 
Fig. 2. Representative images of borrelial lymphocytoma (BL) tissue sections stained with modifi ed Dieterle silver methods and 
Borrelia-specifi c IHC methods as described earlier [30]. White arrows in panel A show the silver-stained spirochetes (i and iv) and 
aggregates (ii and iii), and panel B shows one of the silver-stained aggregates (panel Aiii) stained positive for Borrelia antigen. As a 
negative control for the immunohistochemical method, panel Bvii shows a no antibody control on consecutive section, and panel Bviii 
is the DIC image of the panel Bvii section to prove that there is still aggregate on the tissue section. 400× magnifi cation, bar: 200 μm
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Fig. 3. A representative image shows a validation study for our 16S rDNA fl uorescent in situ hybridization (FISH) protocol using dif-
ferent bacterial cells. The different bacterial cells placed on microscope slides and fi xed and FISH protocols were carried out as de-
scribed in Materials and methods section. The same FISH protocols were carried out on every experiment for Borrelia afzelii (panels 
A and B), Borrelia garinii (panels C and D), Treponema denticola (panels E and F), Borrelia burgdorferi (panels G and H), Borrelia 
hermsii (panels I and J), and Escherichia coli (panels K and L). DAPI nuclear stains depicting the cell morphology (panels B, D, F, H 
J, and L). 400× magnifi cation, bar: 100 μm
Fig. 4. Fluorescent in situ hybridization (FISH) of the BL tissues. Borrelia-specifi c 16S rDNA probe was utilized in these experiments 
to localize Borrelia DNA (A). As comprehensive negative controls, a competing oligonucleotide (B), DNase-treated samples (C), and 
a random DNA probe (D) were used on consecutive tissue sections to further show the specifi city of the 16S rDNA probe (further 
details of the experimental conditions are in Materials and methods section). The tissue morphology was demonstrated with DAPI 
nuclear (E) and differential interphase contrast microscopy (DIC, panel F). 400× magnifi cation, bar: 200 μm
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staining) on the consecutive slide. Figure 2, panel Bviii, 
is a differential interference contract microscopy (DIC) 
image of Fig. 2, panel Bvii, demonstrating that there is 
still Borrelia aggregate on the slide despite the absence of 
staining.
Fluorescence in situ hybridization (FISH) and PCR
further prove Borrelia DNA presence in BL tissues
To further confi rm that the silver-stained aggregates ob-
served in the BL tissues are indeed borrelial aggregates, we 
performed FISH experiments using a B. burgdorferi sensu 
lato-specifi c 16S rDNA probe. The specifi city of our in 
situ hybridization method was fi rst confi rmed using com-
mercially available laboratory strains for B. burgdorferi, 
B. garinii, B. afzelii, B. hermsii, T. denticola, and E. coli 
(see Materials and methods section). Figure 3 shows that 
all Borrelia species stained positive while non-Borrelia 
species such as T. denticola and E. coli were found nega-
tive for Borrelia-specifi c DNA probe.
After validation of the experimental conditions with 
laboratory strains, we have used this Borrelia-specifi c 
FISH protocol on BL tissues sections. Figure 4 shows a 
representative image of the FISH experiments that dem-
onstrates that an aggregate found in BL tissues was suc-
cessfully hybridized with Borrelia-specifi c 16S rDNA 
probe without signifi cant background noise (A). As com-
prehensive negative controls, a competing oligonucleotide 
(B), DNase-treated samples (C), and a random probe (D) 
experimental conditions were used on consecutive tissue 
sections to show the specifi city of the 16S rDNA FISH 
probe. None of the negative control experimental condi-
tions resulted in signifi cant fl uorescent signal, providing 
evidence that the FISH experimental procedure is specifi c 
for Borrelia DNA.
Further validation of the presence of Borrelia spp. 
in the BL tissue biopsies was provided by extracting 
the genomic DNA and amplifying B. burgdorferi sensu 
lato-specifi c16S rDNA. Genomic DNA extracted from a 
B. afzelii laboratory strain (BO23) was used as a positive 
control, and no template control was used as negative 
controls. Figure 5 demonstrates the result of the PCR 
experiments demonstrating the expected PCR bands in 
both the DNA extracted from the BL skin sections (S1–
S6) as well as in the laboratory strain positive control 
(Fig. 5). No PCR products were seen in the no template 
samples (−C), thus eliminating the possibility of con-
tamination and, therefore, a nonspecifi c amplifi cation in 
the PCR reaction. All PCR products were sequenced and 
analyzed by the BLAST program (NCBI) and identifi ed 
to have 99–100% identity to the B. afzelii 16S rDNA 
gene compared to the B. afzelii K78 reference strain ob-
tained from an Austrian cutaneous lesion, thus confi rm-
ing the presence of B. afzelii DNA in our European BL 
biopsies.
Presence of biofilm markers associated
with the aggregates in BL tissues
Having conclusively demonstrated the presence of Bor-
relia spirochetes and aggregates in BL tissues, we next 
asked whether the Borrelia-positive aggregates found in 
the BL tissue are biofi lms. A hallmark characteristic of 
biofi lms is the presence of extracellular polysaccharides 
which play major roles in protection, immune evasion, 
and antibiotic resistance. We had previously shown that 
the biofi lms formed by various Borrelia species are rich 
in mucopolysaccharides and share similarities with bio-
fi lms formed by other bacteria [32–39]. We characterized 
the presence of mucopolysaccharides using an adaptation 
of the Spicer & Meyer aldehyde fuchsine–alcian blue se-
quential staining method (see Materials and methods sec-
tion), which can differentiate between sulfated and non-
sulfated/carboxylated mucins. Fuchsia/purple coloration 
indicates sulfated mucins while blue coloration indicates 
non-sulfated/carboxylated mucins. Results of this stain-
ing method show that Borrelia-positive aggregates in BL 
biopsies have similar staining pattern to the in vitro Bor-
relia aggregates found previously [30] staining for both 
sulfated (fuchsia/purple) and non-sulfated (blue) mucins. 
Fig. 5. Representative agarose gel picture of a Borrelia burgdor-
feri sensu lato specifi c 16S rDNA PCR amplifi cation of genomic 
DNAs obtained from borrelial lymphocytoma skin sections. 
Lane M: 1 kb DNA Ladder (Life Technologies). Genomic DNA 
extracted from Borrelia afzelii laboratory strain (positive control, 
+C) and no template negative control (−C). Genomic DNAs ex-
tracted from borrelial lymphocytoma skin sections located in the 
S1–S6 lanes. The bands seen in lanes of +C and S1–S6 (~450 bp) 
represent DNA amplifi ed using Borrelia-specifi c primers which 
have a target size of 445 bp, indicating the presence of Borrelia 
burgdorferi sensu lato DNA in the samples. No bands were seen 
in the negative control (−C)
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Fig. 6. Representative images showing Spicer & Meyer aldehyde fuchsine–alcian blue sequential staining pattern of two aggregates 
(white arrows) found in the BL tissues via dark fi eld (panels A and C) and by differential interference contrast (panels B and D) mi-
croscopy methods. Fuchsia/purple colorations are indicative of sulfomucins and blue coloration indicates non-sulfated, carboxylated 
mucins. 400× magnifi cation, bar: 200 μm
Fig. 7. Representative images of IHC analyses of spirochetes and aggregates found in BL tissues costained with Borrelia (green) and 
alginate (red) antibodies on the same tissue sections (panels A and B as well as D and E) or consecutive tissue section (panels G and H). 
As negative control, the same IHC experiments were repeated on normal foreskin tissue sections (panels J and K). Differential interfer-
ence contrast (DIC) images were provided to show the morphology of the tissues (panels C, F, I, and L). 400× magnifi cation, bar: 200 μm
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Figure 6 shows the Spicer & Meyer staining pattern of two 
representative aggregates (white arrows) found in the BL 
biopsies by dark fi eld (Fig. 6A and C) and DIC microscopy 
methods (Fig. 6B and D). The images depicting all three 
colors: fuchsia, purple, and blue indicate various muco-
polysaccharides with different chemical composition on 
the surface of Borrelia aggregates in the BL tissues.
Taken together, these results demonstrate that the ag-
gregates found in BL tissues are Borrelia-positive by two 
independently performed IHC and FISH techniques and 
they do contain certain biofi lm markers such as muco-
polysaccharides on their surfaces. The blue coloration 
on the surface of the aggregates indicated non-sulfated 
mucins which strongly suggested alginate presence simi-
larly to what we found on the surface of in vitro Borrelia 
biofi lms.
Borrelia aggregates, but not spirochetes,
strongly express alginates
In the following experiments, the goal was to confi rm that 
Borrelia aggregates indeed have alginate on their surfaces, 
by different immunostaining methods using Borrelia- and 
alginate-specifi c antibodies. Alginate antibody used in this 
study was validated in our previous in vitro studies show-
ing that it does not stain individual Borrelia spirochetes 
as well as certain E. coli biofi lms [30, 39]. As additional 
independent control, we have also used 20 commercial-
ly purchased normal human foreskin sections. Figure 7 
shows representative images of BL sections positively 
costained with both Borrelia- and alginate-specifi c anti-
bodies (Fig. 7A–B and D–E). We also repeated the double 
staining experiments on consecutive slides using Borrelia 
and alginate antibodies to demonstrate independent Bor-
relia and alginate stainings on the same biofi lm (Fig. 7G 
and H).
To further prove that the primary Borrelia- and algi-
nate-specifi c antibodies do not have unspecifi c staining 
on human skin tissue, we have repeated the above experi-
ments on human foreskin sections (Fig. 7J and K). Also, all 
individual spirochetes (Fig. 7A and D; white arrowheads) 
were all alginate negative (Fig. 7B and E), a result, which 
further demonstrates that alginate is specifi c to Borrelia 
aggregates and the two antibodies used in these experi-
ments do not cross-react.
In the next experiments, we repeated the IHC experi-
ments with Borrelia- and alginate-specifi c antibodies us-
ing 1200 sections (200 sections/specimen). While the 
majority of the sections contained at least one Borrelia 
immunopositive spirochete (none of them stained for al-
ginate), only ~5% of all the sections contained Borrelia-
positive aggregates with all different sizes. Figure 8 rep-
resents a summary graph of the number of the spirochetes 
(ranging from 350 to 480 spirochetes/200 sections/speci-
men) and the number of aggregates (ranging from 4 to 12 
aggregates/200 sections/specimen) observed in the six BL 
tissues (BL1-BL6) as well as in the commercially pur-
chased normal human foreskin tissue specimens (control). 
There were no detectable Borrelia-positive spirochetes or 
aggregates found in any of the control specimens. Statisti-
cal analyses of the number of spirochetes or aggregates 
detected in the six BL tissues showed no signifi cant differ-
ences among the specimens (p values >0.05).
IHC fi ndings demonstrated that every Borrelia aggre-
gate, but not any of the observed spirochete, was also posi-
Fig. 8. Graphical representation of the number of the spirochetes and the number of aggregates observed in 1200 sections of six BL 
tissues (BL1-BL6; 200 sections/specimen) as well as in commercially purchased normal human foreskin tissue specimens (20 speci-
mens). Y-axes data shows the number of the spirochetes (ranging from 350 to 480 spirochetes/200 sections/specimen) and the number 
of aggregates (ranging from 4 to 12 aggregates/200 sections/specimen) found in the six BL tissue. There were no detectable spiro-
chetes or aggregates found in any of the control specimens
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tive for alginate. Very importantly, nonspecifi c alginate 
staining was not observed anywhere else in the BL skin 
tissues. Figure 9 shows the heterogeneity in sizes of Bor-
relia aggregates in BL biopsies which were positive for 
both Borrelia and alginate antigens.
Merged images show the localization of alginate asso-
ciated with Borrelia-positive aggregates in sections which 
were dual stained with both anti-Borrelia (green) and 
anti-alginate (red) antibodies (Fig. 10, panels v and vi). 
The yellow colored regions in the merged fi gures show re-
gions, which contain both Borrelia and alginate antigens. 
Bright fi eld images showing the skin tissue stained with 
Sudan black B (Fig. 10, panels vii and viii) show the size 
and morphology of the skin tissue.
Combined FISH and IHC experiments further provide 
evidence that Borrelia aggregates indeed express
alginate on their surfaces
Alternatively, the expression of alginate on the surface of 
Borrelia-positive aggregates in BL skin tissues was also 
detected using a combined FISH and IHC experiments 
with 16S rDNA probe for Borrelia detection and alginate 
antibody for alginate antigen detection. Figure 11 shows a 
representative image which shows that a Borrelia-specifi c 
FISH positive structure (A) stains for alginate (B) as well 
as detected by IHC method. As a negative control, a com-
peting oligonucleotide FISH was included to demonstrate 
the specifi city of the Borrelia FISH DNA probe (C).
Fig. 9. Immunohistochemical staining of BL skin sections showing several different aggregates stained positive with Borrelia (green 
staining: panels A, D, G, and J) and alginate specifi c antibodies (red staining: panels B, E, H and K). Differential interference micro-
scopy (DIC) showing the size and tissue morphology of the skin tissues (panels C, F, I, and L). 400× magnifi cation, bar: 200 μm
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Fig. 10. IHC staining of BL skin sections showing two different aggregates stained positive with Borrelia antigen (green staining: 
panels i and ii) and alginate (red staining: panels iii and iv). Panels v and vi are a merge of the anti-Borrelia and anti-alginate antibody. 
Panels vii and viii show the bright fi eld image with Sudan Black-B staining. In the merged picture, yellow/light orange indicates the 
regions where both Borrelia and alginate are present. 1000× magnifi cation, bar: 200 μm
Fig. 11. Combined FISH and IHC representative image of Borrelia aggregates in BL skin tissues showing that Borrelia-DNA-positive 
structures identifi ed with FISH experiment using 16S rDNA probe (green staining, panel A) express alginate antibody (blue staining, 
panel B) as depicted with an independent IHC method. To show that the structure indeed is Borrelia DNA positive, competing oligo-
nucleotide was used as a negative control (panel C). Differential interference microscopy (DIC) showing the size and tissue morphol-
ogy of the skin tissues (panel D). 400× magnifi cation, bar: 200 μm
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Ultra structural analysis of the Borrelia- and alginate-
positive aggregates in BL biopsies by atomic force
microscopy (AFM)
Finally, to understand the ultrastructural organization of 
Borrelia and alginate dual positive aggregates, we per-
formed atomic force microscopy. Figure 12 shows repre-
sentative micrographs of a dual stained Borrelia aggregate 
costained with both Borrelia- and alginate-specifi c anti-
bodies, which is deeply embedded in the surrounding tis-
sues, observed using DIC microscopy (Fig. 12B). AFM 
topographical scans also confi rmed that the aggregates are 
indeed embedded in the tissues (indicated by the red ar-
rows) and have the characteristic channels and protrusions 
that we observed in the in vitro Borrelia biofi lms (red and 
green arrowheads respectively) (Fig. 12A).
Discussion
We have previously provided evidence that B. burgdorferi 
sensu stricto and sensu lato, the Lyme disease causing spi-
rochete bacteria, are capable of forming biofi lms in vitro 
[30, 38]. The goal of this study was to fi nd and characterize 
potential Borrelia biofi lms in vivo using infected skin tis-
sues of BL biopsies from Austrian Lyme disease patients. 
Our fi ndings demonstrated that the observed aggregates 
are indeed Borrelia-positive structures that express spe-
cifi c biofi lm markers such as sulfated and non-sulfated 
mucopolysaccharides which are mainly alginate. Our data 
also demonstrated that the observed Borrelia-positive spi-
rochetes do not express alginate which further support the 
hypothesis that those Borrelia-positive aggregates are in-
deed biofi lm structures. Our AFM studies further charac-
Fig. 12. Three-dimensional atomic force microscopy analyses of Borrelia/alginate-positive aggregates from a BL biopsy tissue sec-
tion. Panel A shows a representative image from the AFM analyses which was performed using contact mode of the Nanosurf Easys-
can 2 AFM with SHOCONG probe (AppNANO™ [30]). Images were processed, and measurements were obtained using Gwyddion 
software. The individual height and width ranges are indicated on the panels. Panel B shows evidence that the scanned tissue is Bor-
relia- and alginate-positive by fl uorescent IHC analyses (400× magnifi cation). Red arrows represent the same area of the tissue illus-
trated on panels A and B. Red and green arrowheads indicate potential channels and protrusions in the Borrelia/alginate-positive ag-
gregates, bar: 200 μm
E. Sapi et al.
European Journal of Microbiology and Immunology
14
terized the ultrastructure of Borrelia- and alginate-positive 
aggregates and found additional biofi lm characteristic 
properties such as channels and protrusions of the tissue-
embedded biofi lms.
Human biopsies used in this study were lesions from 
BL from Lyme disease patients, a skin condition known 
for the presence of Borrelia spirochetes and reported 
mainly from Europe [42].
BL biopsies were previously analyzed for the different 
morphological forms of Borrelia through focus-fl oating 
microscopy methods [41]. Findings from this study re-
vealed the presence of Borrelia spirochetes as clusters of 
granular colonies. These descriptions are consistent with 
an aggregate of organisms enmeshed in a matrix, similar 
to the Borrelia biofi lm found in vitro [30, 38]. To deter-
mine whether the Borrelia aggregates described in BL 
biopsies are indeed biofi lms, BL biopsy tissues from the 
same archive collection were reexamined for biofi lm-spe-
cifi c markers. Our results on human BL biopsy sections 
fi rst revealed the presence of Borrelia spirochetes and 
aggregates by Borrelia-specifi c IHC methods combined 
with additional silver staining, FISH techniques. To con-
fi rm the specifi city of our techniques, we provided sev-
eral independent negative controls for both the IHC and 
FISH experiments such as: 1) the samples were analyzed 
independently in European and in US laboratories respec-
tively; 2) Borrelia and alginate IHC experiments were 
performed on the same and sequential slides; 3) use of un-
infected human foreskin samples and no antibody control 
in the immunohistochemical experiments; 4) validation 
of our FISH experiments with borrelial and non-borrelial 
laboratory strains; 5) different in situ hybridization nega-
tive controls (competing oligonucleotide, random DNA 
probes, and DNase-treated samples); and 6) combined 
IHC–FISH experiments, which all provided evidence that 
the results are indeed specifi c and do not represent back-
ground tissue staining.
Our fi ndings also suggested that those Borrelia-posi-
tive aggregates, but not spirochetes, have several classical 
features of biofi lm structures because they were strongly 
positive for different mucopolysaccharides as well as for 
alginate, a negatively charged sugar polymer. Pseudo-
monas aeruginosa, the causative agent of cystic fi brosis, 
forms biofi lms rich in alginate that confer it protection 
from the host immune system [33, 35, 45–47]. Studies fur-
ther reported that these biofi lms are very resistant to anti-
biotics and result in chronic infl ammation and damage to 
cystic fi brosis lung tissues. In other studies, however, it 
was confi rmed that even after the degradation of the algi-
nate present on the biofi lm surface, the gentamycin resis-
tance of the biofi lm was not affected [46]. This implies that 
alginate might not be the only reason for the resistance of 
biofi lms and that there are other components which confer 
antibiotic resistance. The exact role of alginate presence 
on the surface on Borrelia aggregates in the infected skin 
tissues still needs to be determined as well as the other po-
tential protective layers indicated by our Spicer & Meyer 
fi ndings.
The presence of alginate on the Borrelia-positive struc-
tures in LB tissues also provides a good argument against 
the theory called “amber hypothesis” which hypothesizes 
that dead spirochetes and borrelial debris can persist in the 
tissue and cause chronic infl ammation in Lyme disease pa-
tients [48, 49]. The authors of these studies argued against 
the idea of potential biofi lm because the isolated Borrelia 
aggregates found in mouse skin tissues failed to grow in 
vitro. Culture negativity of biofi lms from different patho-
gens is one of the cornerstone concepts for the behavior 
of true biofi lms [50, 51] as it was shown in biofi lms in 
culture-negative orthopedic and endocardiatic biofi lm in-
fections [51, 52] and therefore cannot be used to dismiss 
the idea that Borrelia can make biofi lm in vivo.
Among the order Spirochaetales, biofi lms from T. den-
ticola and Leptospira spp. have already been reported in 
periodontal diseases and dental water systems, respective-
ly [37, 53]. Further investigation of T. denticola biofi lm 
development revealed that it could be achieved in vitro 
on fi bronectin surfaces in a low-shear-force environment 
[54]. We also found that certain surfaces are preferable for 
Borrelia biofi lm formation in vitro such as collagen and 
fi bronectin surfaces [30, 38], which correlates well with 
the results from this study where Borrelia aggregates were 
found in collagen- and fi bronectin-rich skin tissues. Our 
differential interference contrast and atomic force micros-
copy data also showed that the Borrelia biofi lms embed-
ded deeply in the tissue suggesting a potential host tissue 
rearrangement during biofi lm growth. The exact mecha-
nism of host tissue remodeling during the dissemination of 
B. burgdorferi is under active investigation and suggests 
the use of a variety of bacterial factors and host enzymes; 
therefore, it is very likely that those Borrelia aggregates 
could use the same mechanism to embed the biofi lm in the 
tissues and further protect the structure from the host de-
fense. Findings from this study could also raise the ques-
tion about the kind of other tissues that could be potential 
target for these Borrelia biofi lm structures. In one of our 
ongoing mouse studies, we have analyzed multiple tissue 
sites in Borrelia-infected Balb/c mice model and found 
in multiple tissues with similar Borrelia-positive aggre-
gates with alginate presence [55]. We are also in the pro-
cess studying the molecular mechanism of the antibiotic 
resistance of Borrelia aggregates using different Borrelia 
mutant cell lines and identifi ed important pathways which 
might be responsible for the observed resistance. For ex-
ample, Lux S quorum sensing defi cient Borrelia mutant 
showed incomplete biofi lm development and reduced re-
sistance against certain antibiotics, a result which agrees 
with the potential function of Lux S pathway during mam-
malian infection [56, 57].
In summary, in this study, we provided several lines of 
evidence that Borrelia biofi lm could exist in vivo. Further 
confi rmation and characterization of the presence of bio-
fi lm in vivo would help us better understand the survival 
strategies of the Borrelia spp. within its host and would 
provide important clinical data for therapeutic intervention 
for Lyme disease patients.
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